Organon & Co
907 hedge funds and large institutions have $5.47B invested in Organon & Co in 2021 Q4 according to their latest regulatory filings, with 150 funds opening new positions, 214 increasing their positions, 415 reducing their positions, and 155 closing their positions.
3.3% more ownership
Funds ownership: 68.14% → 71.45% (+3.3%)
5% more call options, than puts
Call options by funds: $34M | Put options by funds: $32.4M
3% less capital invested
Capital invested by funds: $5.65B → $5.47B (-$182M)
3% less first-time investments, than exits
New positions opened: 150 | Existing positions closed: 155
2% less funds holding
Funds holding: 927 → 907 (-20)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
48% less repeat investments, than reductions
Existing positions increased: 214 | Existing positions reduced: 415
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$40.9M |
| 2 |
GCM
Glenview Capital Management
New York
|
-$24.7M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$24M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$18.5M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$17.4M |
OGN Hedge Fund Activity: Q4 2021 in Review
907 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q4 2021, worth a combined $5.47B — down 3.2% from $5.65B a quarter earlier.
Sellers outnumbered buyers: 155 funds closed out of OGN and 150 opened new positions — a net loss of 5 holders — while 415 trimmed existing stakes and 214 added.
The largest buyer was Bank of New York Mellon, adding an estimated $98.7M. The largest seller was Wellington Management Group, cutting an estimated $40.9M.
- 907 institutional investors held Organon & Co (OGN) as of Q4 2021, down from 927 in Q3 2021.
- Funds reported $5.47B of Organon & Co stock for Q4 2021, down 3.2% quarter-over-quarter.
- 150 funds opened new Organon & Co positions in Q4 2021 and 155 closed out, a net change of -5 holders.
- The largest Organon & Co buyer in Q4 2021 was Bank of New York Mellon, an estimated $98.7M added.
- The largest Organon & Co seller in Q4 2021 was Wellington Management Group, an estimated $40.9M sold.
Based on aggregated 13F filings for Q4 2021.